ADKINS SEALE CAPITAL MANAGEMENT LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 2147212
SHREVEPORT, LA
Position in ACAD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$7,590
+$912 QoQ
Shares Held
300
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#298
of 350 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADKINS SEALE CAPITAL MANAGEMENT LLC holds $116,499 across 5 Biotechnology names. ACAD ranks #4 (6.5% of the industry book) .
All Filings in ACAD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,590 | 300 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,678 | 300 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $8,013 | 300 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||